Sorafenib and TRC105 in Hepatocellular Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial
- Status
- UNKNOWN
- Phase
- PHASE2
E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY2157299 in Participants With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)
- Status
- UNKNOWN
- Phase
- N/A
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Sorafenib in Urothelium Cancer of Bladder
- Status
- TERMINATED
- Phase
- PHASE2
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE3
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
- Status
- COMPLETED
- Phase
- PHASE1
Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1